Spain Wound Care Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Spain Wound Care Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Spain's Wound Care Management Market is poised to register a CAGR of 4.7% over the forecast period.

The COVID-19 pandemic had a significant impact on the wound care management market in Spain owing to factors such as reduced cases of accidents and chronic wounds, which were majorly attributed to the lockdown all over the country and the restriction on non-emergency procedures in the hospitals. However, chronic wounds were found in COVID patients across the country. For instance, as per the Spain-specific study published by the National Institute of Health in June 2022, a study was carried out on around 119 patients with acute and chronic wounds. The prevalence of chronic wounds was around 7.6%, and the incidence was 3.5% in the internal medicine units. Pressure injuries (PIs) were the most common wounds, and COVID-19-affected patients had a higher risk of developing pressure ulcers. Furthermore, due to the fear of COVID transmission in hospitals, people were unable to receive significant treatment during the pandemic.However, as restrictions are lifted, the market is expected to grow in the coming years due to an increase in chronic wounds, an increase in accident cases, and new product launches.

The major factors driving the growth of the market in Spain include increasing incidences of chronic wounds and ulcers, diabetic foot ulcers, and the rising burden of diabetes. For instance, according to the article published by the National Institute of Health in February 2021 in PubMed, chronic wounds were becoming more widespread in Barcelona every year and were more common among women. In addition, diabetic foot ulcers were playing a crucial role in the increasing burden of chronic wounds in Barcelona. The rate of prevalence in the general population was around 6.7% to 12%. Furthermore, as per the IDF Atlas, 10th Edition, the number of people with diabetes in Spain was 5,141.3 in 2021. This number is anticipated to rise to 5,576 by 2030. Hence, an increase in the number of diabetes cases is likely to boost the chance of acquiring diabetic foot ulcers in patients. Due to the slow rate of wound healing in diabetic patients, people with foot ulcers frequently use wound care medications. Thus, as the number of diabetic cases rises, the market is expected to witness growth over the forecast period.

Furthermore, key players are expanding their wound care portfolio in Spain, which significantly drives market growth. For instance, in April 2021, Bactiguard expanded its business in the wound care market by partnering with the Spanish company Farmaban S.A. The partnership enables Bactiguard to reach the Spanish market with its full range of products. Hence, considering all these factors, the market is expected to show significant growth over the forecast period.

Thus, due to the rise in chronic wounds, increase in product launches, and strategic collaborations by the key players, the Spain wound care management market is anticipated to witness growth over the forecast period. However, high treatment costs associated with wound care management are hindering market growth to some extent.

Sutures can be absorbable or nonabsorbable. Absorbable sutures are naturally dissolved in the body and eventually dissolve completely, whereas non-absorbable sutures should be manually removed. Absorbable sutures are made from synthetic polymer materials, such as polylactic acid (Vicryl), polyglycolic acid (Dexon), polyglyconate (Maxon), and polydioxanone (PDS). The suture segment is anticipated to witness growth in the studied market owing to factors such as a rise in accident cases, an increase in chronic wounds, and a surge in suture product launches in the country.

Furthermore, the rise in accident cases causes injuries, and demand for suturing open wounds increases, thereby driving market growth. For instance, as per the Ministry of Labor and Social Economy's 2022 report, 408 156 mild accident cases were reported in 2021, and this count is expected to rise to 460 113 in 2022 in Spain. As per the same source, 320,228 males and 143,660 females encountered an accident in 2022. As the number of accident cases rises, the demand for sutures increases, thereby boosting market growth over the forecast period.

Thus, due to the rise in accident cases, increase in product launches, and strategic collaborations by the key players, the studied segment is expected to witness growth in the market over the forecast period.

The diabetic foot ulcer segment is anticipated to witness growth in the studied market owing to factors such as a rise in diabetes cases, an increase in healthcare expenditures, and a surge in product launches in the country. For instance, as per the IDF Atlas, 10th edition, 32.8% of gestational diabetes cases were reported in Spain in 2021. As per the same source, the health care expenditure on diabetes was estimated at USD 15,453.6 million in 2021 in Spain. The healthcare expenditures for diabetes include wound care for diabetic foot ulcers. The estimated diabetic healthcare expenditure in 2035 is likely to be USD 15,625.3 million. Thus, a rise in healthcare expenditure is likely to drive market growth by encouraging more investment in wound care management, thereby boosting market growth over the forecast period.

Furthermore, the rise in clinical studies regarding diabetic foot ulcers is anticipated to increase the opportunities for wound care products in Spain. For example, in April 2021, the Universidad Complutense de Madrid will run a clinical trial to find out how ultrasound debridement affects the area and how fast diabetic foot ulcers heal compared to how they are usually treated.

Thus, due to the rise in diabetes cases, increase in healthcare expenditure, and clinical studies on diabetic foot ulcers, the studied segment is expected to witness growth in the market over the forecast period.

Spain's wound management market is fragmented due to the presence of many international and local players in the country. The companies are also showing continuous growth and are developing new and differentiated products and services that address the evolving healthcare needs of patients, providers, and consumers. Some of the companies that are currently dominating the market are 3M, Medtronic PLC, Smith & Nephew, ConvaTec Group PLC, Coloplast A/S, Cardinal Health, Inc., Molnlycke Health Care, and Integra Lifesciences.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support